p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation

Beatrice Eymin1, Paule Claverie, Caroline Salon

  • 1INSERM U578, Groupe de Recherche sur le Cancer du Poumon, Université Joseph Fourier, La Tronche, France. Beatrice.Eymin@ujf-grenoble.fr

Insights

The p14ARF tumor suppressor triggers a p53-independent G2 arrest by activating ERK1/2 MAP kinases. This pathway phosphorylates Cdc25C at Ser216, leading to its degradation and cell cycle arrest.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • Cdc25C phosphatase regulates mitotic entry, with phosphorylation at Ser216 inducing inactivation via 14-3-3 binding.
  • p14ARF, a tumor suppressor, previously shown to induce inactive Cdc25C(Ser216) and p53-independent G2 arrest.

Purpose of the Study:

  • Investigate the signaling pathways mediating p14ARF-induced G2 arrest.
  • Identify the role of ERK1/2 MAP kinases in this process.
  • Determine if Cdc25C is a direct target of ERK1/2.

Main Methods:

  • Utilized pharmacological inhibitors to probe signaling pathways.
  • Assessed protein levels and phosphorylation status of Cdc25C and ERK1/2.
  • Investigated protein-protein interactions and ubiquitination/degradation pathways.

Main Results:

  • p14ARF expression activates the ERK1/2 MAP kinase pathway, inducing a p53-independent G2 checkpoint.
  • Activated ERK1/2 directly phosphorylates Cdc25C at Ser216, identifying Cdc25C as a novel ERK1/2 target.
  • Phosphorylation at Ser216 by ERK1/2 promotes Cdc25C ubiquitination and proteasomal degradation, essential for sustained G2 arrest.

Conclusions:

  • The MAPK ERK signaling pathway is crucial for p14ARF's p53-independent antiproliferative functions.
  • p14ARF-induced G2 arrest involves ERK1/2-mediated phosphorylation and subsequent degradation of Cdc25C.
  • This study reveals a new mechanism for Cdc25C inactivation through Ser216 phosphorylation and proteolysis.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...